Menu Back toSession-3-Innovation-in-Pediatric-Development-Formulation-Trial-Design-and-Real-World-Data

Better Medicines for Children, A DIA/EFGCP Conference

Plan ahead and join us to reflect on the importance of two major headways that are currently affecting Paediatric research: Innovative approaches to Drug Development and impact of the current environment on the Regulatory and Research Infrastructure


Session 3: Innovation in Pediatric Development: Formulation, Trial Design and Real World Data

Session Chair(s)

Siri  Wang, PhD

Siri Wang, PhD

  • Scientific Director; PDCO Member
  • Norwegian Medicines Agency, Norway
Session 3: Innovation in Pediatric Development: Formulation, Trial Design and Real World Data

Speaker(s)

Joerg  Breitkreutz

Beyond Tablets and Liquids – Update on new Concepts for Paediatric Formulations

Joerg Breitkreutz

  • Professor of Pharmaceutical Technology
  • Heinrich-Heine-University Düsseldorf, Institute of Pharmaceutics and Biopharmace, Germany
Anja  Schiel, PhD

Innovative Trial Designs - How Much Can We Use Data from Adults?

Anja Schiel, PhD

  • Senior Adviser/Statistician, Unit for HTA and Reimbursement
  • Norwegian Medicines Agency (NoMA), Norway
Elin Haf Davies, BSN, PhD

Title Registries, Apps, Wearables - How Does Real World Data Change the Way We Do Studies?

Elin Haf Davies, BSN, PhD

  • Founder/CEO
  • aparito, United Kingdom

Contact us


Registration Questions?

Send Email
+41 61 225 51 51